Page URL:

Signs of change in US stem cell policy?

13 November 2006
Appeared in BioNews 384

By Antony Blackburn-Starza:
There's a feeling of change in relation to embryonic stem (ES) cell research in the US following the mid-term elections, which saw the Democrats capturing both the Senate and the House of Representatives from the Republicans.

In the state of Missouri, where ES cell research was a contentious issue in the run up to the elections, voters elected Claire McCaskill as their Senator after she campaigned in favour for ES cell research. In a ballot vote, the state also approved an amendment to their constitution permitting ES cell research, which includes embryo cloning, by a narrow 51 per cent majority. The amendment will make it constitutional to clone embryos to be used in stem cell research but prohibits human reproductive cloning. Importantly, the change will not allow Missourian courts from ruling against ES cell research. The vote came as good news for stem cell research companies based in the state. The Stowers Institute for Medical Research, based in Missouri, now hopes to recruit prominent scientists who work with stem cells. They issued a statement saying that the initiative will enable the company to compete for prominent stem cell scientists on a global level.

Federally, now that the Democrats hold a majority in both the Senate and the House, other pro-stem cell states may now attempt to introduce legislation expanding federal funding for research. In July, President Bush vetoed the Stem Cell Research Enhancement Act, which would have increased the types of stem cells that are eligible for funding. At the time, the House of Representatives lacked the two-thirds majority that is required to override a presidential veto. Even with the Republican losses, however, the current Democrat majority is probably too narrow for pro-stem cell legislation to gain the needed weight. However, now that US public support of stem cell research is increasing, Bush may be more restrained from exercising his veto again.

Nor is it likely that more funds will be available for ES cell research with Democratic control of the budget agenda. Nancy Pelosi, who is set to become the speaker of the House in January 2007, has promised to extend federal funds for more types of stem cell research than currently allowed in her first 100 hours of leadership. However, even though the Democrats will control the budget agenda, it does not necessarily mean that more funds will be available for stem-cell research, said Jon Rezlaff of the Federation of American Societies for Experimental Biology. 'You're still talking about huge expenses for the Iraq war and everything else', he pointed out.

Meanwhile, the Pluripotent Stem Cell Therapies Enhancement Act, which directs the National Institutes of Health to support ways of cultivating stem cells that do not destroy embryos, may get a second change in a so-called 'lame duck' session of Congress before it breaks for holidays. The bill has already been unanimously passed by the Senate last July but failed in the House. The Act is part of a number of science bills to be considered, but it is not considered very likely to be passed.

Antiabortion Activists Refocusing Strategies After Election Results; Washington Post Says Democratic-Controlled Congress Might Force Bush To Reconsider Stance on Embryonic Stem Cell Research
Kaiser Network |  9 November 2006
Science bills head to lame duck session
The Scientist |  9 November 2006
Stem-cell researchers welcome midterm results
New Scientist |  9 November 2006
US scientists weigh up election results
New Scientist |  9 November 2006
7 December 2009 - by Ben Jones 
A Missouri Republican State Representative has proposed legislation to block public spending on embryonic stem cell (ES cell) research in the state. The proposed amendment to the Missouri constitution called for an end to public funding of any research that involved the destruction of embryos. The pro-life Republican representative, Cynthia Davis, also included a ban on funding for abortion and any use of cloning technologies...
23 April 2007 - by Sam Berger and Professor Jonathan Moreno 
It appears that once again the US Congress will be unable to override President Bush's expected veto of legislation to loosen federal restrictions on human embryonic stem (ES) cell research. In light of this political stalemate, as well as efforts in states like California, New Jersey, and New York to...
17 April 2007 - by Antony Starza-Allen 
The Senate has passed two pieces of legislation designed to relax the restrictions on stem cell research in the US. It has approved a much-anticipated bill to ease current restrictions on human embryonic stem cell (ES) research, allowing for federal funding to be used for research on...
26 March 2007 - by Antony Starza-Allen 
The director of the US National Institutes of Health (NIH), Elias Zerhouni, has said that he supports the removal of the current restrictions on federal funding for human embryonic stem (ES) cell research imposed by President Bush in 2001. 'From my standpoint, it is clear today that...
15 January 2007 - by Antony Starza-Allen 
The US House of Representatives has voted in favour of legislation to expand federal funding for human embryonic stem (ES) cell research. The Stem Cell Research Enhancement Act 2007 was passed by 253 votes to 174, but fell short of the two-thirds majority needed to override a...
6 November 2006 - by Antony Starza-Allen 
A vote will take place this week in the US state of Missouri on proposed changes the State's constitution to allow all kinds of stem cell research to take place. The Missouri Stem Cell Research and Cures Initiative - also known as Amendment 2 - will permit so-called therapeutic...
20 July 2006 - by Dr Kirsty Horsey 
US President George Bush has vetoed a bill passed by Congress that would have removed restrictions on federally-funded human embryonic stem (ES) cell research in America. The bill - known as the Stem Cell Research Enhancement Act of 2005 (HR 810) - was debated alongside two other bills...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.